In a patient with neurofibromatosis type I at cesarean delivery, bleeding was not correctable by oxytocin, methylergonovine and PGF2 alpha given together.
In plain wordsIn one patient, bleeding after cesarean delivery was not stopped by oxytocin given with two other uterus-contracting drugs.
- Peptide
- Oxytocin
- Outcome
- No significant changeControl of uterine and surgical site bleeding at cesarean delivery
- Study
n = 1
- Outcome group
- Sex hormones and fertility · Reproductive and sexual health
Source sentences
had diffuse uterine and surgical site bleeding that was not correctable by oxytocin, methylergonovine and PGF2 alpha.
1 context sentence(design, population, supporting numbers)
A patient with the genetic condition neurofibromatosis type I and no known coagulopathy undergoing cesarean delivery, had diffuse uterine and surgical site bleeding that was not correctable by oxytocin, methylergonovine and PGF2 alpha.
In this study, Oxytocin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Oxytocin.